Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

Artesunate for Injection

Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance.

Terminated Sterility / contamination Amivas (US), LLC NDC 73607-001-02 D-0002-2022
Class II · Moderate risk

ceFAZolin

Lack of sterility assurance.

Terminated Sterility / contamination IntegraDose Compounding Services LLC NDC 71139-7087-1 D-0896-2021
Class II · Moderate risk

Mic 25/50/50mg/Ml Mdv

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0062-2022
Class II · Moderate risk

Methylcobalamin 10

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0058-2022
Class II · Moderate risk

Folic Acid 10mg/Ml Mdv Inj

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0057-2022
Class II · Moderate risk

Calcium Gluconate 10% Inj

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0056-2022
Class II · Moderate risk

Acetylcysteine 2% Opth Soln

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0054-2022
Class II · Moderate risk

Acetylcysteine 10% Opth Soln

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Terminated Sterility / contamination First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0053-2022